Saudi Arabia Platelet Rich Plasma (prp) Market Size & Outlook

The platelet rich plasma (prp) market in Saudi Arabia is expected to reach a projected revenue of US$ 11.6 million by 2030. A compound annual growth rate of 18% is expected of Saudi Arabia platelet rich plasma (prp) market from 2024 to 2030.
Revenue, 2023 (US$M)
$3.7
Forecast, 2030 (US$M)
$11.6
CAGR, 2024 - 2030
17.7%
Report Coverage
Saudi Arabia

Saudi Arabia platelet rich plasma (prp) market, 2018-2030 (US$M)

Saudi

Saudi Arabia platelet rich plasma (prp) market highlights

  • The Saudi Arabia platelet rich plasma (prp) market generated a revenue of USD 3.7 million in 2023 and is expected to reach USD 11.6 million by 2030.
  • The Saudi Arabia market is expected to grow at a CAGR of 18% from 2024 to 2030.
  • In terms of segment, pure prp was the largest revenue generating type in 2023.
  • Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.


Platelet rich plasma (prp) market data book summary

Market revenue in 2023USD 3.7 million
Market revenue in 2030USD 11.6 million
Growth rate18% (CAGR from 2023 to 2030)
Largest segmentPure prp
Fastest growing segmentLeukocyte Rich PRP
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPure PRP, Leukocyte Rich PRP
Key market players worldwideJohnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.6% of the global platelet rich plasma (prp) market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 5.5 million by 2030.

Pure prp was the largest segment with a revenue share of 51.35% in 2023. Horizon Databook has segmented the Saudi Arabia platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.


Hair loss has been a long-standing concern for men, and it remains a prevalent issue in Saudi Arabia. Alopecia areata exhibits a higher prevalence in Saudi Arabia compared to Western countries, with an earlier age of onset.

This condition tends to affect males more than females, and the onset occurs at a relatively younger age in women. In response to the demand for effective hair loss solutions, PRP hair treatment has become a popular choice in major cities, such as Riyadh and Jeddah.

Saudi Arabia faces a significant health challenge, with one in every four Saudi adults with diabetes mellitus. Moreover, over 44% of individuals aged 55 years and older in the country suffer from long-term complications related to severe or uncontrolled diabetes.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Platelet Rich Plasma (PRP) Market Companies

Name Profile # Employees HQ Website

Saudi Arabia platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)

Saudi Arabia Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)

Saudi Arabia platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more